Login
$EW
$90.82 +$0.26 (0.29%) Close

Insider Transactions

What Edwards Lifesciences Corporation's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 9 54
Total trades 17 157

Shares traded

3 months 12 months
Acquired 33,657 589,373
Disposed 39,805 470,314
Net activity −6,148 +119,058

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Lippis Daniel J. CVP, TAVR Oct 08 Disclosed 10b5-1 sale · S −619 $85.65 −$53K 40,034
Lippis Daniel J. CVP, TAVR Oct 08 Exercise / conversion · M +619 $72.68 +$45K 40,653
Markowitz Wayne CVP, JAPAC Sep 14 Withheld — tax / exercise cost · F −568 $84.37 −$47.9K 19,371
Dahl Andrew M. SVP, Corporate Controller Sep 13 Withheld — tax / exercise cost · F −253 $84.37 −$21.3K 14,615
Markowitz Wayne CVP, JAPAC Sep 11 Withheld — tax / exercise cost · F −355 $86.77 −$30.8K 19,939
Lippis Daniel J. CVP, TAVR Sep 11 Disclosed 10b5-1 sale · S −619 $87.51 −$54.2K 40,034
Lippis Daniel J. CVP, TAVR Sep 11 Exercise / conversion · M +619 $72.68 +$45K 40,653
Chopra Daveen CVP, TMTT, Surgical & IHFM Sep 11 Withheld — tax / exercise cost · F −398 $86.77 −$34.5K 43,926
Dahl Andrew M. SVP, Corporate Controller Aug 31 Open-market sale · S −544 $91.06 −$49.5K 14,868
Bruls Annette CVP, EMEACLA Aug 28 Open-market sale · S −2,644 $89.98 −$238K 17,984
Chopra Daveen CVP, TMTT, Surgical & IHFM Aug 26 Open-market sale · S −30,646 $90.99 −$2.79M 44,324
Chopra Daveen CVP, TMTT, Surgical & IHFM Aug 26 Open-market sale · S −1,154 $91.76 −$106K 74,970
Chopra Daveen CVP, TMTT, Surgical & IHFM Aug 26 Exercise / conversion · M +31,800 $72.68 +$2.31M 76,124
Markowitz Wayne CVP, JAPAC Aug 26 Open-market sale · S −1,240 $91.47 −$113K 20,294
Lippis Daniel J. CVP, TAVR Aug 11 Disclosed 10b5-1 sale · S −619 $92.03 −$57K 40,034
Lippis Daniel J. CVP, TAVR Aug 11 Exercise / conversion · M +619 $72.68 +$45K 40,653
Markowitz Wayne CVP, JAPAC Jul 30 Open-market sale · S −146 $86.03 −$12.6K 21,534
Markowitz Wayne CVP, JAPAC Jul 28 Open-market sale · S −9,628 $85.06 −$819K 21,680
Markowitz Wayne CVP, JAPAC Jul 28 Exercise / conversion · M +9,628 $74.02 +$713K 31,308
Zovighian Bernard J CEO Jul 27 Open-market sale · S −2,921 $83.93 −$245K 8,916

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support